A review of the cost of cardiovascular disease

World Health Organization. Cardiovascular disease: Prevention and control. Global strategy on diet, physical activity and health. 2007. <http://www.who.int/dietphysicalactivity/publications/facts/cvd/en/> (Version current at August 8, 2007). Centers for Disease Control and Prevention. Division for heart disease and stroke prevention: Addressing the nation's leading killers. At a glance 2007. Chronic Disease Prevention. <http://www.cdc.gov/nccdphp/publications/aag/dhdsp.htm> (Version current at August 8, 2007). Statistics Canada. Mortality: Summary list of causes 2003. Catalogue number 84F0209XIE. Ottawa: Minister of Industry, 2006. <http://www.statcan.ca/cgi-bin/downpub/listpub.cgi?catno=84F0209XIE2003000> (Version current at March 4, 2006). OANDA Corporation. <http://www.oanda.com/> (Version current at August 8, 2007). Organization for Economic Co-operation and Development. Consumer price indices (MEI). OECD.Stat. The organization. <http://stats.oecd.org/wbos/default.aspx> (Version current at August 8, 2007). OECD. Country statistical profiles 2007. OECD.Stat. <http://stats.oecd.org/WBOS/default.aspx?DatasetCode=CSP2007> (Version current at August 8, 2007). World Health Organization. Point prevalence for selected causes: By sex, age and WHO subregion. <http://www.who.int/healthinfo/statistics/gbdwhoregionprevalence2001.xls> (Version current at August 8, 2007). 2006, Heart disease and stroke statistics – 2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 113, e85, 10.1161/CIRCULATIONAHA.105.171600 Birnbaum, 2003, Lifetime medical costs for women: Cardiovascular disease, diabetes, and stress urinary incontinence, Womens Health Issues, 13, 204, 10.1016/S1049-3867(03)00073-2 Garis, 2002, Examining costs of chronic conditions in a Medicaid population, Managed Care, 11, 43 Health Canada. Economic Burden of Illness in Canada in 1998. Ottawa: Health Canada, 2002. <http://www.phac-aspc.gc.ca/publicat/ebic-femc98/> (Version current at August 8, 2007). Leal, 2006, Economic burden of cardiovascular diseases in the enlarged European Union, Eur Heart J, 27, 1610, 10.1093/eurheartj/ehi733 Sasser, 2005, Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population, Womens Health Issues, 15, 97, 10.1016/j.whi.2004.11.006 Wang, 2004, Physical activity, cardiovascular disease, and medical expenditures in U.S. adults, Ann Behav Med, 28, 88, 10.1207/s15324796abm2802_3 Chan, 1998, Cost of stroke in Ontario, 1994/95, CMAJ, 159, 2 Dewey, 2001, Cost of stroke in Australia from a societal perspective: Results from the North East Melbourne Stroke Incidence Study (NEMESIS), Stroke, 32, 2409, 10.1161/hs1001.097222 Ekman, 2004, Economic evidence in stroke: A review, Eur J Health Econ, 5, S74, 10.1007/s10198-005-0292-3 Goeree, 2005, Cost of stroke in Canada: A 1-year prospective study, J Med Econ, 8, 147, 10.3111/200508147167 Kolominsky-Rabas, 2006, Lifetime cost of ischemic stroke in Germany: Results and national projections from a population-based stroke registry: The Erlangen Stroke Project, Stroke, 37, 1179, 10.1161/01.STR.0000217450.21310.90 Samsa, 1999, Epidemiology of recurrent cerebral infarction: A medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost, Stroke, 30, 338, 10.1161/01.STR.30.2.338 Sloan, 1999, Costs and outcomes of hip fracture and stroke, 1984 to 1994, Am J Public Health, 89, 935, 10.2105/AJPH.89.6.935 Teng, 2003, Costs and caregiver consequences of early supported discharge for stroke patients, Stroke, 34, 528, 10.1161/01.STR.0000049767.14156.2C Truelsen, 2005, Cost of stroke in Europe, Eur J Neurol, 12, 78, 10.1111/j.1468-1331.2005.01199.x Rossnagel, 2005, Medical resource use and costs of health care after acute stroke in Germany, Eur J Neurol, 12, 862, 10.1111/j.1468-1331.2005.01091.x Amin, 1999, Direct health care costs for treatment of diabetes mellitus and hypertension in an IPA-group-model HMO, Am J Health Syst Pharm, 56, 1515, 10.1093/ajhp/56.15.1515 Berto, 2002, The pandora project: Cost of hypertension from a general practitioner database, Blood Press, 11, 151, 10.1080/080370502760050386 Degli Esposti, 2001, The PANDORA project: Results of the cost of illness analysis, J Hum Hypertens, 15, 329, 10.1038/sj.jhh.1001178 Druss, 2001, Comparing the national economic burden of five chronic conditions, Health Affairs, 20, 233, 10.1377/hlthaff.20.6.233 Garis, 2001, The incremental cost of chronic illnesses: A medicaid database analysis, J Res Pharm Econ, 11, 21, 10.1300/J063v11n03_03 Goetzel, 2004, Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers, J Occup Environ Med, 46, 398, 10.1097/01.jom.0000121151.40413.bd Hodgson, 2001, Medical care expenditures for hypertension, its complications, and its comorbidities, Medical Care, 39, 599, 10.1097/00005650-200106000-00008 Kiiskinen, 1998, Long-term cost and life-expectancy consequences of hypertension, J Hypertens, 16, 1103, 10.1097/00004872-199816080-00004 Maetzel, 2004, The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: A comparative study, Ann Rheum Dis, 63, 395, 10.1136/ard.2003.006031 Xuan, 2000, The economic burden of congestive heart failure in a managed care population, Am J Manag Care, 6, 693 Eisenstein, 2001, Assessing the clinical and economic burden of coronary artery disease: 1986–1998, Medical Care, 39, 824, 10.1097/00005650-200108000-00008 Etemad, 2005, Total first-year costs of acute coronary syndrome in a managed care setting, J Manag Care Pharm, 11, 300, 10.18553/jmcp.2005.11.4.300 Javitz, 2004, Cost of illness of chronic angina, Am J Manag Care, 10, S358 Levy, 2003, The comparative medical costs of atherothrombotic disease in European countries, Pharmacoeconomics, 21, 651, 10.2165/00019053-200321090-00003 Liu, 2002, The economic burden of coronary heart disease in the UK, Heart, 88, 597, 10.1136/heart.88.6.597 Migliaccio-Walle, 2005, Costs and medical care consequences associated with the diagnosis of peripheral arterial disease, Pharmacoeconomics, 23, 733, 10.2165/00019053-200523070-00007 Russell, 1998, Direct medical costs of coronary artery disease in the United States, Am J Cardiol, 81, 1110, 10.1016/S0002-9149(98)00136-2 Stewart, 2003, The current cost of angina pectoris to the National Health Service in the UK, Heart, 89, 848, 10.1136/heart.89.8.848